Biotech componentsMolecule

Products 21 to 30 of 38

Porcupine (synthetic DNA tagging system) by University of Washington
Biotech components: Molecule
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:51 (2 years ago)
Date last modified: 2020/12/18 14:51 (2 years ago)
Known funding amount: N/A
Funding types: University
Industry: Multipurpose + Novelty
Market status: Early Stage Concept
Organization type(s): University
Product categories: Other
Production process: N/A
Source: N/A
Trading symbol: N/A
Value chain stage: Input + Platform
PRGN-3005: Cancer by Intrexon
Biotech components: Gene Editing + Molecule
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 14:31 (3 years ago)
Date last modified: 2019/09/12 14:31 (3 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Medical
Market status: Under Development
Organization type(s): Public Company
Product categories: Medical Treatment
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product
Biotech components: Gene Editing + Molecule
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 14:32 (3 years ago)
Date last modified: 2019/09/12 14:32 (3 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Medical
Market status: Under Development
Organization type(s): Public Company
Product categories: Medical Treatment
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Project Cyborg by Autodesk
Biotech components: Molecule
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2018/08/30 11:49 (4 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Science
Market status: Under Development
Organization type(s): Public Company
Product categories: Design
Production process: Closed Production
Source: SynBio Database
Trading symbol: ADSK (NASDAQ)
Value chain stage: Platform
Biotech components: Molecule
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Research
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2018/10/01 09:18 (4 years ago)
Known funding amount: 70,000,000 USD
Funding types: Private Funding
Industry: Food & Agriculture
Market status: On the market
Organization type(s): Private Company
Product categories: Research
Production process: Closed Production
Source: Web search
Trading symbol: N/A
Value chain stage: Platform
RNA-based Biocontrols by Syngenta
Biotech components: Molecule
Business models: B2B
Country of production: Switzerland
Country of distribution: Switzerland
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2018/10/02 11:25 (4 years ago)
Known funding amount: 2,147,483,647 USD
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: Under Development
Organization type(s): Public Company
Product categories: Plant
Production process: Open Release
Source: NASEM Database
Trading symbol: SYT (NYSE)
Value chain stage: Input
SentryBox by Applied DNA Sciences
Biotech components: Molecule
Business models: B2C
Country of production: USA
Country of distribution: North America
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2019/01/30 12:02 (4 years ago)
Known funding amount: 19,800,000 USD
Funding types: Shareholder Investment
Industry: Security
Market status: On the market
Organization type(s): Public Company
Product categories: Forensic Tagging
Production process: Closed Production
Source: NASEM Database
Trading symbol: APDN (NASDAQ)
Value chain stage: Finished Product
SER150DN by Serodus + Evolva
Biotech components: Molecule
Business models: B2B
Country of production: USA
Country of distribution: N/A
Intended consumer: N/A
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2018/11/09 16:29 (4 years ago)
Known funding amount: 102,000,000 NOK
Funding types: Private Funding
Industry: Health
Market status: Under Development + More information needed
Organization type(s): Private Company
Product categories: Medical Treatment
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Finished Product
SigNature DNA by Applied DNA Sciences
Biotech components: Molecule
Business models: B2C
Country of production: USA
Country of distribution: USA + Turkey + Africa + UK
Intended consumer: Commercial + Government
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2019/01/30 12:01 (4 years ago)
Known funding amount: 19,800,000 USD
Funding types: Shareholder Investment
Industry: Security
Market status: On the market
Organization type(s): Public Company
Product categories: Forensic Tagging
Production process: Closed Production
Source: NASEM Database
Trading symbol: APDN (NASDAQ)
Value chain stage: Finished Product
SigNature T by Applied DNA Sciences
Biotech components: Molecule
Business models: B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2019/01/30 12:00 (4 years ago)
Known funding amount: 19,800,000 USD
Funding types: Shareholder Investment
Industry: Security
Market status: On the market
Organization type(s): Public Company
Product categories: Forensic Tagging
Production process: Closed Production
Source: NASEM Database
Trading symbol: APDN (NASDAQ)
Value chain stage: Finished Product